(Q34262624)

1 August 2017

1 reference

title

Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

Legato MJ

1

1 reference

PubMed ID

11374849

1 August 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

American Journal of Cardiology

1 August 2017

1 reference

1 August 2017

86

1 reference

1 August 2017

15L-18L

1 reference

1 August 2017

12A

1 reference

Contributions of the Framingham Study to the conquest of coronary artery disease

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Invest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901463-6

10.1016/S0002-9149(00)01463-6

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11374849